DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Stock Report

Market Cap: US$6.3b

DENTSPLY SIRONA Management

Management criteria checks 2/4

DENTSPLY SIRONA's CEO is Simon Campion, appointed in Sep 2022, has a tenure of 1.58 years. total yearly compensation is $8.52M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth $1.95M. The average tenure of the management team and the board of directors is 1.4 years and 4.6 years respectively.

Key information

Simon Campion

Chief executive officer

US$8.5m

Total compensation

CEO salary percentage11.7%
CEO tenure1.6yrs
CEO ownership0.03%
Management average tenure1.4yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Dentsply Sirona Seems Unaffected By Management Reshuffles

May 02

Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

Apr 29
Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist

DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Rather Sparingly

Mar 16
DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Rather Sparingly

CEO Compensation Analysis

How has Simon Campion's remuneration changed compared to DENTSPLY SIRONA's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$9mUS$1m

-US$132m

Sep 30 2023n/an/a

-US$214m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023n/an/a

-US$1b

Dec 31 2022US$8mUS$304k

-US$950m

Compensation vs Market: Simon's total compensation ($USD8.52M) is about average for companies of similar size in the US market ($USD8.28M).

Compensation vs Earnings: Simon's compensation has increased whilst the company is unprofitable.


CEO

Simon Campion (51 yo)

1.6yrs

Tenure

US$8,518,987

Compensation

Mr. Simon D. Campion serves as Chief Executive Officer at DENTSPLY SIRONA Inc. since September 12, 2022 and also serves as its President & Director since September 2022. He served as an Executive Vice Pres...


Leadership Team

NamePositionTenureCompensationOwnership
Simon Campion
CEO, President & Director1.6yrsUS$8.52m0.031%
$ 1.9m
Glenn Coleman
Executive VP & CFO1.6yrsUS$3.90m0.012%
$ 774.5k
Richard Rosenzweig
Executive VP1.2yrsUS$4.35m0.0050%
$ 313.8k
Andreas Frank
Executive Vice President & Chief Business Officer2yrsUS$3.75m0.013%
$ 843.1k
Robert Johnson
Senior VP & Chief Supply Chain Officerno dataUS$2.94m0.010%
$ 629.5k
Richard Wagner
Chief Accounting Officer1.7yrsno data0.00099%
$ 62.4k
Kevin Boyle
Senior VP & Chief Technology Officerless than a yearno datano data
Andrea Daley
Vice President of Investor Relationsno datano datano data
Andrea Frohning
Senior VP & Chief Human Resources Officerless than a yearno datano data
Erania Brackett
Senior VP of Orthodontic Aligner Solutions & Customer Experience and Head of Sustainabilityless than a yearno data0.0072%
$ 451.8k
Andrew Robinson
Senior Vice President of North America RCO2.1yrsno datano data
Emily Miner
Senior VP & Chief Quality Officerless than a yearno datano data

1.4yrs

Average Tenure

53.5yo

Average Age

Experienced Management: XRAY's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Simon Campion
CEO, President & Director1.6yrsUS$8.52m0.031%
$ 1.9m
Eric Brandt
Independent Non-Executive Director19.4yrsUS$456.25k0.028%
$ 1.8m
Clyde Hosein
Independent Director3.6yrsUS$300.00k0.0062%
$ 388.2k
Betsy Holden
Independent Director6.3yrsUS$315.00k0.0013%
$ 82.5k
Leslie Varon
Independent Director6.3yrsUS$325.00k0.0096%
$ 606.2k
Brian Gladden
Independent Directorless than a yearUS$25.00kno data
Gregory Lucier
Independent Chairman4.9yrsUS$318.75k0.025%
$ 1.6m
William Deese
Independent Director13.2yrsUS$320.00k0.014%
$ 896.7k
Janet Vergis
Independent Director4.6yrsUS$315.00k0.0078%
$ 494.7k
Ilse Wenzel
Independent Director2.2yrsUS$310.00k0.0021%
$ 134.9k
Jonathan Mazelsky
Independent Directorless than a yearUS$260.44kno data

4.6yrs

Average Tenure

61yo

Average Age

Experienced Board: XRAY's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.